HALLE (SAALE), Germany — Navigo Proteins announces the appointment of Dr. Florian Settele as Managing Director of Navigo Pure with immediate effect. In his role, Florian will navigate the company on its journey to further strengthen and expand its position as a provider of best‑in‑class affinity chromatography products. As such, Navigo Pure is committed to building a strong pipeline of catalogue and customized products that support robust, scalable, and cost‑effective biopharmaceutical manufacturing.

Dr. Settele contributes his outstanding experience in the field. As Head of Navigo Pure, he evolved into a key player, securing and solidifying the success of the company’s business. His appointment marks the next step in the company’s continued evolution and growth.

“It is a privilege to take on this new responsibility as Managing Director of Navigo Pure,” said Dr. Florian Settele. “Having been part of the company’s journey for 15 years, I look forward to building on this strong foundation together with our team and further expanding Navigo Pure’s position as an innovative partner in downstream bioprocessing.”

“Florian’s appointment is a natural next step for Navigo Pure and for Navigo Proteins. He qualifies uniquely for this exciting position and will continue to structure and shape Navigo Pure’s future and success. I am more than happy to see him taking on this responsibility and leading Navigo Pure into its next chapter as Managing Director.” – Dr. Henning Afflerbach, CEO of Navigo Proteins.

Dr. Settele worked at the German Cancer Research Center (DKFZ) and received his PhD in Cell and Molecular Biology from the University of Heidelberg and later completed an MBA at HHL Leipzig Graduate School of Management. Since joining Navigo Proteins in 2011, he has contributed to the company in positions spanning research and development, external collaborations, commercial alliances, and business unit leadership.

Dr. Florian Settele, Managing Director of Navigo Pure

About Navigo Pure
Navigo Pure is fully owned by Navigo Proteins and dedicated to redefining downstream bioprocessing through its proprietary Precision Capturing® platform. The company develops next-generation affinity ligands and chromatography solutions that enable efficient, scalable purification of complex biotechnological products. Navigo Pure supports biopharmaceutical partners in improving process performance and reducing manufacturing complexity.
For more information visit www.navigo-pure.com or follow us on LinkedIn.